Strategic Plan: Opportunities and Future Directions
With significant improvements in cancer treatment, clinical trials have
moved towards a precision medicine framework with scientific aims
focused on optimizing QOL and minimizing toxicities while maintaining
high survival rates. COG offers a unique collaborative environment to
evaluate scientific aims with behavioral science outcomes in the context
of large clinical trials with representative samples of children and
AYAs with cancer from diverse racial, ethnic, and socioeconomic
backgrounds. Aligned with our mission to improve outcomes for children
with cancer and their families, the BSC is poised to contribute to the
scientific advances of trials aiming to improve outcomes and promote
evidence-based supportive care interventions to be translated into
routine care.